Patients choose us because: Were local and trusted in Oldham Our staff are friendly, approachable, and professional We explain things clearly, no medical jargon We genuinely care about your health, not just ticking boxes For many people, just having someone local they can rely on makes the whole process easier
UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
Each vial contains 5mg BPC-157 and 5mg TB-500 (10mg total)
L., Zaman, R., Rehman, N., & Tan, C